Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
Quick Stats
Jan 30, 202638.7
AI Score
SELL0.95
Volume Ratio
Feb 25, 2026
Next Earnings
10
+ve Days (30d)
20
-ve Days (30d)
JUNS Stock Summary
Last updated Jan 30, 2026
JUNS is currently trading at $0.5278, positioned below its 200-day moving average of $1.21, suggesting bearish momentum. The stock has a 52-week range of $0.48 to $3.33.
Technical Analysis: The 50-day moving average stands at $1.05, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 18.953, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.591, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates JUNS at 38.7/100 with a SELL recommendation.
JUNS (Jupiter Neurosciences, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 18.953 |
| CMF (20) | -0.591 |
| ROC (10) | -38.777 |
| ADX (14) | 39.926 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.123 |
| AROONOSC (14) | -92.857 |
| WILLAMS %R (14) | -92.164 |
| MFI (14) | 2.378 |
JUNS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
JUNS Price vs Max Options Open Interest
JUNS Max Change In Options Open Interest
JUNS Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JUNS Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JUNS Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JUNS Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Jupiter Neurosciences, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
JUNS Moving Averages Analysis
JUNS (Jupiter Neurosciences, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 0.79 |
| 20 | 0.89 |
| 30 | 0.96 |
| 50 | 1.05 |
| 100 | 1.27 |
| 200 | 1.21 |
JUNS Fundamental Analysis
| P/E (Forward) | 8.6281 |
| P/E (Trailing) | -- |
| Market Cap ($) | 18.2 million |
| Earnings/Share ($) | -0.23 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.26 |
| EPS Estimate Next Year ($) | 0.06 |
| WallStreet Target Price ($) | 30 |
| Most Recent Quarter |